Here are relevant reports on : health-monitoring-devices-market
-
Cold Chain Monitoring Market by Sensors and Data Loggers, RFID Devices, Telematics & Telemetry Devices, Networking Devices, Logistics (Storage, Transportation), Application (Pharmaceuticals & Healthcare, Food & Beverages) - Global Forecast to 2030
The global cold chain monitoring market is expected to grow from USD 8.31 billion in 2025 to USD 15.04 billion by 2030, at a compound annual growth rate (CAGR) of 12.6% during the forecast period. The Key Players Carrier (US), Testo SE & Co. KGaA (Germany), Cryoport Inc. (US), ORBCOMM (US), Controlant hf. (Iceland), Zebra Technologies Corp. (US), Xylem (US), Digi International Inc. (US), AgroFresh (US), and Rotronic AG (Switzerland).
- Published: September 2025
- Price: $ 4950
- TOC Available:
-
Patient Monitoring Devices – Emerging Markets BRIC(Brazil, Russia, India, China) 2010-2015
The Emerging Markets: BRIC (Brazil, Russia, India and China) Patient Monitors witnesses significant growth opportunities due to rapidly aging population, high incidence of chronic diseases, and government initiatives such as reform in healthcare delivery systems. Despite the impact of economic slowdown, BRIC nations are expected to grow at a CAGR of around 10 - 12% from 2009 – 2014.
- Published: July 2010
- Price: $ 4950
- TOC Available:
-
Cardiac Monitoring & Cardiac Rhythm Management Devices Market by Monitoring (ECG (Holter, ILR), COM), Rhythm Management (Defibrillators (ICD, AED), Pacemaker), Application (Heart Failure, Arrhythmias, MI), Procedure (Invasive) & Region - Global Forecast to 2029
The global cardiac monitoring & cardiac rhythm management devices market, valued at US$20.7 billion in 2023, stood at US$21.3 billion in 2024 and is projected to advance at a resilient CAGR of 4.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.4 billion by the end of the period. Market growth in the Asia Pacific can be attributed to the increasing adoption of sedentary lifestyles, changing diets, increasing stress, and habitual smoking and drinking, and rising morbidity and mortality from CVD.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Neonatal Care Equipment Market by Product (Neonatal Incubators, Convertible Warmers & Incubators, Respiratory Care Devices (Neonatal Ventilators), Monitoring Devices (Pulse Oximeters)), End User (General and Pediatric Hospitals) - Global Forecast to 2030
The global neonatal care equipment market, valued at US$2.0 billion in 2024, stood at US$2.2 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of US$2.8 billion by the end of the period. The neonatal care equipment market is driven by rising preterm birth rates, advancements in neonatal technology, and increasing government initiatives to reduce infant mortality.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Cardiovascular Devices Market by Product (Cardiac Imaging, Rhythm Management, Cardiac Assist Devices, Interventional Cardiology, Electrophysiology, Monitoring ), Indication (CAD, MI, CHF), End User (Hospitals & Clinics) - Global Forecast to 2029
The global cardiovascular devices market, valued at US$72.83 billion in 2023, stood at US$77.71 billion in 2024 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2029, culminating in a forecasted valuation of US$110.39 billion by the end of the period. The growth of the cardiovascular devices market is primarily due to the increasing prevalence of CVD, the aging population, and the growing prevalence of risk factors like diabetes, hypertension, obesity, and sedentary lifestyle.
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Wireless Monitoring and Surveillance Market by Product (Cameras, Alarms), Devices (Wireless Monitoring, And Surveillance), Application (Healthcare, Security, Retail, Infrastructure, and Entertainment) & Geography -Forecast & Analysis to 2014 – 2020
The demand for security and better monitoring solutions has urged the need for better monitoring and surveillance devices. Wireless monitoring and surveillance devices play an important role for the deployment of improved security systems. The wireless monitoring systems helpsin monitoring such places where it is not feasible or convenient to include cables. Wireless organizations also play an important role for monitoring and controlling the wireless operations. The advantages offered by wireless monitoring and surveillance devices are improved security, high quality, and wide coverage range.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Ophthalmic Equipment Market by Technology (AI-enabled Equipment), Product Type (Surgical Devices (Ophthalmic Microscopes), Diagnostic & Monitoring Devices (Optical Coherence Tomography Scanners, Slit Lamps) ), End User (Hospitals) - Global Forecast to 2030
The global ophthalmic equipment market, valued at US$18.61 billion in 2024, stood at US$19.65 billion in 2025 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2030, culminating in a forecasted valuation of US$26.14 billion by the end of the period.
- Published: November 2025
- Price: $ 7150
- TOC Available:
-
Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029
The global udder health market, valued at US$1.13 billion in 2023, stood at US$1.18 billion in 2024 and is projected to advance at a resilient CAGR of 5.9% from 2024 to 2029, culminating in a forecasted valuation of US$1.58 billion by the end of the period. The growth in the udder health market can be attributed to the factors, including increasing investments, funds, and grants by governments and other organizations, rising number of veterinarians in the developing countries.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
